Boneva Roumiana S, Lin Jin-Mann S, Maloney Elizabeth M, Jones James F, Reeves William C
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
Health Qual Life Outcomes. 2009 Jul 20;7:67. doi: 10.1186/1477-7525-7-67.
Chronic fatigue syndrome (CFS) is a debilitating condition of unknown etiology and no definitive pharmacotherapy. Patients are usually prescribed symptomatic treatment or self-medicate. We evaluated prescription and non-prescription drug use among persons with CFS in Georgia and compared it to that in non-fatigued Well controls and also to chronically Unwell individuals not fully meeting criteria for CFS.
A population-based, case-control study. To identify persons with possible CFS-like illness and controls, we conducted a random-digit dialing telephone screening of 19,807 Georgia residents, followed by a detailed telephone interview of 5,630 to identify subjects with CFS-like illness, other chronically Unwell, and Well subjects. All those with CFS-like illness (n = 469), a random sample of chronically Unwell subjects (n = 505), and Well individuals (n = 641) who were age-, sex-, race-, and geographically matched to those with CFS-like illness were invited for a clinical evaluation and 783 participated (48% overall response rate). Clinical evaluation identified 113 persons with CFS, 264 Unwell subjects with insufficient symptoms for CFS (named ISF), and 124 Well controls; the remaining 280 subjects had exclusionary medical or psychiatric conditions, and 2 subjects could not be classified. Subjects were asked to bring all medications taken in the past 2 weeks to the clinic where a research nurse viewed and recorded the name and the dose of each medication.
More than 90% of persons with CFS used at least one drug or supplement within the preceding two weeks. Among users, people with CFS used an average of 5.8 drugs or supplements, compared to 4.1 by ISF and 3.7 by Well controls. Persons with CFS were significantly more likely to use antidepressants, sedatives, muscle relaxants, and anti-acids than either Well controls or the ISF group. In addition, persons with CFS were significantly more likely to use pain-relievers, anti-histamines and cold/sinus medications than were Well controls.
Medical care providers of patients with chronic fatigue syndrome should be aware of polypharmacy as a problem in such patients, and the related potential iatrogenic effects and drug interactions.
慢性疲劳综合征(CFS)是一种病因不明且尚无确切药物治疗方法的使人衰弱的病症。患者通常接受对症治疗或自行用药。我们评估了佐治亚州慢性疲劳综合征患者的处方药和非处方药使用情况,并将其与非疲劳的健康对照者以及未完全符合慢性疲劳综合征标准的长期不适个体进行比较。
一项基于人群的病例对照研究。为了识别可能患有类似慢性疲劳综合征疾病的人和对照者,我们对19807名佐治亚州居民进行了随机数字拨号电话筛查,随后对5630人进行了详细的电话访谈,以识别患有类似慢性疲劳综合征疾病、其他长期不适以及健康的受试者。所有患有类似慢性疲劳综合征疾病的人(n = 469)、慢性不适受试者的随机样本(n = 505)以及与患有类似慢性疲劳综合征疾病的人年龄、性别、种族和地理位置匹配的健康个体(n = 641)均受邀进行临床评估,783人参与(总体应答率为48%)。临床评估确定了113名慢性疲劳综合征患者、264名症状不足以诊断为慢性疲劳综合征的不适受试者(称为ISF)以及124名健康对照者;其余280名受试者有排除性的医学或精神疾病,2名受试者无法分类。受试者被要求将过去两周内服用的所有药物带到诊所,由一名研究护士查看并记录每种药物的名称和剂量。
超过90%的慢性疲劳综合征患者在过去两周内使用了至少一种药物或补充剂。在使用者中,慢性疲劳综合征患者平均使用5.8种药物或补充剂,而ISF组为4.1种,健康对照者为3.7种。慢性疲劳综合征患者使用抗抑郁药、镇静剂、肌肉松弛剂和抗酸剂比健康对照者或ISF组显著更频繁。此外,慢性疲劳综合征患者使用止痛药、抗组胺药和感冒/鼻窦药物比健康对照者显著更频繁。
慢性疲劳综合征患者的医疗服务提供者应意识到多药合用是此类患者的一个问题,以及相关的潜在医源性效应和药物相互作用。